Abstract
BACKGROUND: The resistance to depression therapy remains high, and therapy failure leads to suicide. Curcuma heyneana (C. heyneana) is a plant of Zingiberaceae. Conventionally, the rhizome has been used as an anxiolytic and sedative. However, the activity as antidepression has never been conducted.
AIM: Therefore, this research was aimed to investigate the antidepressant activity of C. heyneana rhizome.
METHODS: This research was conducted using male mice aged 2–3 months. Chronic mild stress for 14 days was used to induce depression, followed by administration of the extract at 50, 100, and 200 mg/kg for 10 days. Evaluation of antidepression was carried out using tail suspension test (TST), forced swim test (FST), open field test (OFT), and blood glucose and injury of gastric. Sertraline at the dose of 6.5 mg/kg was used as a positive control.
RESULTS: The result revealed that stress induction for 14 days causes decreasing in locomotor activity and increased immobility. The extract administration at the doses of 100 and 200 mg/kg showed increased locomotor activity, which can be seen from the elevation of the central square and cross in the OFT (p < 0.05). The extract also decreased immobility in the tail suspension and FSTs (p < 0.05). Furthermore, the extract also prevents increases in blood glucose and gastric irritation.
CONCLUSION: Extract of C. heyneana rhizome at the doses of 100 and 200 mg/kg has antidepressant activity by increasing locomotor activity, decreasing immobility time, and preventing elevation of blood glucose and gastric injury.
Publisher
Scientific Foundation SPIROSKI
Reference38 articles.
1. Delgado PL. Depression: The case for a monoamine deficiency. J Clin Psychiatry. 2000;61(6):7-11. PMid:10775018
2. Teter CJ, Kando JC. Major depressive disorder. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG PL, editors. Pharmacotherapy, Pathophysiologic Approach. 8th ed. United States: McGraw-Hill; 2011. p. 1173-90.
3. Alexander RC, Preskorn S. Clinical pharmacology in the development of new antidepressants: The challenges. Curr Opin Pharmacol. 2014;14:6-10. PMid:24565005
4. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, et al. Sequenced treatment alternatives to relieve depression (STAR* D): Rationale and design. Control Clin Trials. 2004;25(1):119-42. https://doi.org/10.1016/s0197-2456(03)00112-0 PMid:15061154
5. Agoes A. Tanaman Obat Indonesia. Jakarta: Salemba Medika; 2010. p. 99-100.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献